Wednesday 21st October 2020
In the fight against coronavirus, an effective vaccination could be the game-changer that the world is waiting for. It typically takes several years to develop a new vaccine, so how close are we to finding a real vaccination for coronavirus, and how might this work to protect us?
Friday 9th October 2020
Many people are entitled to a free flu jab this year, and you may have received a letter about this. But why is this important and what are the benefits? And is there anyone who should not have the flu vaccine? We have all the answers you need.
Tuesday 29th September 2020
An important part of participating in a project such as this is ensuring that you understand how the collected data will be used and why community input is so valuable and fundamentally vital.
Friday 21st August 2020
A team of researchers based in the USA, UK, Germany, Switzerland and Japan sought to examine the results of the SENSCIS trial to assess the safety and tolerability of nintedanib in people with SSc-ILD.
Friday 26th June 2020
Lenabasum is a synthetic drug that activates a certain receptor involved in the immune system and in the activity of fibroblasts, which drive fibrosis (scarring), and is particularly useful for diffuse cutaneous scleroderma.
Tuesday 28th April 2020
Nintedanib, a drug that slows the rate of lung fibrosis, has been approved as a treatment for individuals with systemic sclerosis-associated interstitial lung disease, the first option to have been made available.
Thursday 5th March 2020
Advice from Public Health England on COVID-19 to help you understand the implications if you have scleroderma and Raynaud's.
Monday 10th February 2020
Despite Raynaud’s syndrome being a relatively common condition, with up to 10 million people in the UK diagnosed, several questions remain about the nature of the disease. We've addressed some of the most frequently asked ones here.
Tuesday 4th February 2020
With winter now upon us – a bad season for Raynaud’s patients – we asked members of our community for tips to avoid triggers and manage their symptoms.
Wednesday 22nd January 2020
Research into many aspects of Raynaud’s syndrome has recently been conducted, but it is crucial that more research is focused on areas such as treatment, diagnoses and causes.
